These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 15712099
1. Quinolones for treatment of nosocomial pneumonia: a meta-analysis. Shorr AF, Susla GB, Kollef MH. Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S115-22. PubMed ID: 15712099 [Abstract] [Full Text] [Related]
2. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. West M, Boulanger BR, Fogarty C, Tennenberg A, Wiesinger B, Oross M, Wu SC, Fowler C, Morgan N, Kahn JB. Clin Ther; 2003 Feb 15; 25(2):485-506. PubMed ID: 12749509 [Abstract] [Full Text] [Related]
3. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience. Tennenberg AM, Davis NB, Wu SC, Kahn J. Curr Med Res Opin; 2006 May 15; 22(5):843-50. PubMed ID: 16709306 [Abstract] [Full Text] [Related]
4. Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial. Shorr AF, Zadeikis N, Jackson WL, Ramage AS, Wu SC, Tennenberg AM, Kollef MH. Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S123-9. PubMed ID: 15712100 [Abstract] [Full Text] [Related]
5. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. Caldwell JW, Singh S, Johnson RH. J Antimicrob Chemother; 1999 Mar 15; 43 Suppl A():129-34. PubMed ID: 10225583 [Abstract] [Full Text] [Related]
6. Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections. Lode H, Wiley E, Olschewski P, Sievers H, Wintermantel M, Baetz R, Lebahn K, Reinke M, Wagner J, Borner K. Scand J Infect Dis Suppl; 1990 Mar 15; 68():50-5. PubMed ID: 2218423 [Abstract] [Full Text] [Related]
7. Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials. Jenkins SG, Fisher AC, Peterson JA, Nicholson SC, Kaniga K. Curr Med Res Opin; 2009 Dec 15; 25(12):3029-36. PubMed ID: 19849650 [Abstract] [Full Text] [Related]
8. Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin. Torres A, Bauer TT, León-Gil C, Castillo F, Alvarez-Lerma F, Martínez-Pellús A, Leal-Noval SR, Nadal P, Palomar M, Blanquer J, Ros F. Thorax; 2000 Dec 15; 55(12):1033-9. PubMed ID: 11083889 [Abstract] [Full Text] [Related]
9. Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia. Joshi M, Metzler M, McCarthy M, Olvey S, Kassira W, Cooper A. Respir Med; 2006 Sep 15; 100(9):1554-65. PubMed ID: 16487695 [Abstract] [Full Text] [Related]
10. [Levofloxacine for the treatment of pneumococcal pneumonia: results of a meta-analysis]. Bru JP, Leophonte P, Veyssier P. Rev Pneumol Clin; 2003 Dec 15; 59(6):348-56. PubMed ID: 14745340 [Abstract] [Full Text] [Related]
11. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. Ioannidou E, Siempos II, Falagas ME. J Antimicrob Chemother; 2007 Dec 15; 60(6):1216-26. PubMed ID: 17934205 [Abstract] [Full Text] [Related]
12. [Ciprofloxacin in the treatment of hospital-acquired pneumonia: a surveillance study in 676 patients]. Kljucar S, Rost KL, Landen H. Pneumologie; 2002 Oct 15; 56(10):599-604. PubMed ID: 12375221 [Abstract] [Full Text] [Related]
13. Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Kaye KS, Kanafani ZA, Dodds AE, Engemann JJ, Weber SG, Carmeli Y. Antimicrob Agents Chemother; 2006 Jun 15; 50(6):2192-6. PubMed ID: 16723582 [Abstract] [Full Text] [Related]
14. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E, Tigecycline 301 Study Group, Tigecycline 306 Study Group. Clin Infect Dis; 2005 Sep 01; 41 Suppl 5():S354-67. PubMed ID: 16080073 [Abstract] [Full Text] [Related]
16. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections. Joseph J, Rodvold KA. Expert Opin Pharmacother; 2008 Mar 01; 9(4):561-75. PubMed ID: 18312158 [Abstract] [Full Text] [Related]
17. Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis. Gomis M, Barberán J, Sánchez B, Khorrami S, Borja J, García-Barbal J. Rev Esp Quimioter; 1999 Sep 01; 12(3):244-9. PubMed ID: 10878516 [Abstract] [Full Text] [Related]
18. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Lipsky BA, Holroyd KJ, Zasloff M. Clin Infect Dis; 2008 Dec 15; 47(12):1537-45. PubMed ID: 18990064 [Abstract] [Full Text] [Related]
19. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC, MOTIV (MOxifloxacin Treatment IV) Study Group. Clin Infect Dis; 2008 May 15; 46(10):1499-509. PubMed ID: 18419482 [Abstract] [Full Text] [Related]
20. Levofloxacin in the treatment of ventilator-associated pneumonia. Alvarez-Lerma F, Grau S, Alvarez-Beltrán M. Clin Microbiol Infect; 2006 May 15; 12 Suppl 3():81-92. PubMed ID: 16669931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]